Association of the manufacturers of innovative drugs INOVIA was founded in February 2007. Since May 2010 members of the Association are all 16 innovative pharmaceutical companies that are doing business in Serbia.

INOVIA Mission is to promote technological and economical development of innovative pharmaceutical industry in Serbia and, as leaders in that field, we are devoted to cooperate with all relevant entites that can affect improvement of the Serbian healthcare system. Since 2009, INOVIA is a member of EFPIA, European Federation of Pharmaceutical Industries and Associations, whose codes automatically became mandatory for all member companies of the INOVIA Association.

Ana Govedarica,President of the Board of Directors, Managing Director of Roche
Robert Gal (Hungary), Vice president of the Board of Directors, Managing Director of Sanofi
Jelena Spanovic, member of the Board of Directors, Managing Director of Abott
Predrag Radosevic, member of the Board of Directors, Managing Director of Novo Nordisk
Frederic Ponelle (France), member of the Board of Directors, Managing Director of Les Laboratoires Servier

Jacek Mazurkiewicz, President of SB, Managing Director of Merck
Gianfranco Nazzi, member of SB, Managing Director of AstraZeneca
Milos Androvic, member of SB, MSD